跳至主要内容
临床试验/NCT05009810
NCT05009810Unknown不适用

Efficacy and Safety of Astaxanthin in Volunteer With Refraction Errors

Chulalongkorn University0 个研究点目标入组 180 人开始时间: 2021年8月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
180
主要终点
Visual acuity value

研究概览

简要总结

This study will investigate efficacy and safety of astaxanthin in 180 volunteers with refraction errors. Visual test, skin test, liver function test, renal function test, and adverse event will be evaluated before and after taking astaxanthin for 1 and 2 months.

详细描述

This study will investigate efficacy and safety of astaxanthin in 180 volunteers with refraction errors. They will divided into 3 groups which are astaxanthin 4 mg group , astaxanthin 6 mg group, and placebo group. They will take the sample 1 capsule once daily for 2 months. Visual test, skin test, liver function test, renal function test, and adverse event will be evaluated before and after taking the sample for 1 and 2 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age 18-65 years
  • •Refraction errors, dry eye, or blurred vision
  • •Have a willingness to participate in the study

排除标准

  • •Uncontrolled disease
  • •Have complications during the study
  • •Have astaxanthin more than 2 weeks
  • •Allergic to astaxanthin, seafood, or seaweed
  • •Osteoporosis or thyroid disease
  • •Immunodeficiency or taking immunosuppressants
  • •Liver and kidney diseases
  • •A person with a brain disorder, vision or hearing unusual
  • •Pregnancy or lactation
  • •Cannot follow the protocol
  • •During participated in other studies

研究组 & 干预措施

astaxanthin 4 mg

Experimental

The astaxanthin 4 mg will be taken 1 capsule once daily for 2 months.

干预措施: astaxanthin 4 mg (Dietary Supplement)

astaxanthin 6 mg

Experimental

The astaxanthin 6 mg will be taken 1 capsule once daily for 2 months.

干预措施: astaxanthin 6 mg (Dietary Supplement)

Placebo

Placebo Comparator

The placebo will be taken 1 capsule once daily for 2 months.

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Visual acuity value

时间窗: 2 months

Measured using Snellen Chart (logarithm of the minimal angle of resolution unit)

次要结局

  • Skin humidity value(2 months)
  • Alanine aminotransferase value(2 months)
  • Blood urea nitrogen value(2 months)
  • Adverse events(2 months)
  • Refractive status(2 months)
  • Eye fatigue status(2 months)
  • Skin transepidermal water loss value(2 months)
  • Alkaline phosphatase value(2 months)
  • Vision status(2 months)
  • Skin erythema value(2 months)
  • Skin melanin value(2 months)
  • Aspartate transaminase value(2 months)
  • Creatinine value(2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pornanong Aramwit, Pharm.D., Ph.D

Professor

Chulalongkorn University

相似试验